Suppr超能文献

炎症性肠病:基于中药方剂治疗的概述

Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment.

作者信息

Yuan Shuo, Wang Qi, Li Jiao, Xue Jia-Chen, Li You, Meng Huan, Hou Xiao-Ting, Nan Ji-Xing, Zhang Qing-Gao

机构信息

Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, 133002, Jilin, China.

Chronic Disease Research Center, Medical College, Dalian University, Dalian, 116622, Liaoning, China.

出版信息

Chin Med. 2022 Jun 18;17(1):74. doi: 10.1186/s13020-022-00633-4.

Abstract

Inflammatory bowel disease (IBD) is a chronic recurrent inflammatory disease of the intestine, including Crohn's disease (CD) and ulcerative colitis (UC), whose etiology and pathogenesis have not been fully understood. Due to its prolonged course and chronic recurrence, IBD imposes a heavy economic burden and psychological stress on patients. Traditional Chinese Herbal Medicine has unique advantages in IBD treatment because of its symptomatic treatment. However, the advantages of the Chinese Herbal Medicine Formula (CHMF) have rarely been discussed. In recent years, many scholars have conducted fundamental studies on CHMF to delay IBD from different perspectives and found that CHMF may help maintain intestinal integrity, reduce inflammation, and decrease oxidative stress, thus playing a positive role in the treatment of IBD. Therefore, this review focuses on the mechanisms associated with CHMF in IBD treatment. CHMF has apparent advantages. In addition to the exact composition and controlled quality of modern drugs, it also has multi-component and multi-target synergistic effects. CHMF has good prospects in the treatment of IBD, but its multi-agent composition and wide range of targets exacerbate the difficulty of studying its treatment of IBD. Future research on CHMF-related mechanisms is needed to achieve better efficacy.

摘要

炎症性肠病(IBD)是一种肠道慢性复发性炎症性疾病,包括克罗恩病(CD)和溃疡性结肠炎(UC),其病因和发病机制尚未完全明确。由于病程迁延且慢性复发,IBD给患者带来了沉重的经济负担和心理压力。中药在IBD治疗中具有独特优势,因其能对症治疗。然而,中药复方(CHMF)的优势却鲜有探讨。近年来,许多学者从不同角度对CHMF延缓IBD进行了基础研究,发现CHMF可能有助于维持肠道完整性、减轻炎症并降低氧化应激,从而在IBD治疗中发挥积极作用。因此,本综述聚焦于CHMF治疗IBD的相关机制。CHMF具有明显优势。除了具备现代药物精确的成分和可控的质量外,它还具有多成分、多靶点的协同作用。CHMF在IBD治疗中具有良好前景,但其多药组成和广泛的靶点增加了研究其治疗IBD的难度。未来需要对CHMF相关机制进行研究以获得更好的疗效。

相似文献

1
Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment.
Chin Med. 2022 Jun 18;17(1):74. doi: 10.1186/s13020-022-00633-4.
2
A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease.
Phytomedicine. 2021 Nov;92:153709. doi: 10.1016/j.phymed.2021.153709. Epub 2021 Sep 6.
4
The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S73-S80. doi: 10.1093/jcag/gwy053. Epub 2018 Nov 2.
5
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
J Ethnopharmacol. 2020 Apr 6;251:112442. doi: 10.1016/j.jep.2019.112442. Epub 2019 Dec 28.
6
Bile acids as signaling molecules in inflammatory bowel disease: Implications for treatment strategies.
J Ethnopharmacol. 2025 Jan 30;337(Pt 3):118968. doi: 10.1016/j.jep.2024.118968. Epub 2024 Oct 18.
7
Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
Gastroenterology. 2017 Sep;153(3):723-731.e1. doi: 10.1053/j.gastro.2017.05.056. Epub 2017 Jun 8.
9
The Functional Role of Lactoferrin in Intestine Mucosal Immune System and Inflammatory Bowel Disease.
Front Nutr. 2021 Nov 25;8:759507. doi: 10.3389/fnut.2021.759507. eCollection 2021.
10
Exploring Novel Herbal Compounds and Formulations for Inflammatory Bowel Disease (IBD) Management.
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2023 Dec 16;39:e20230003. doi: 10.62958/j.cjap.2023.003.

引用本文的文献

1
Autophagy in inflammatory bowel disease: immunization, etiology, and therapeutic potential.
Front Immunol. 2025 Aug 6;16:1543040. doi: 10.3389/fimmu.2025.1543040. eCollection 2025.
4
Cynaroside ameliorates TNBS-induced colitis by inhibiting intestinal epithelial cell apoptosis via the PI3K/AKT signalling pathway.
Front Pharmacol. 2025 Jan 20;15:1496068. doi: 10.3389/fphar.2024.1496068. eCollection 2024.
7
Protective effect of sucrose esters from cape gooseberry (Physalis peruviana L.) in TNBS-induced colitis.
PLoS One. 2024 Mar 21;19(3):e0299687. doi: 10.1371/journal.pone.0299687. eCollection 2024.

本文引用的文献

2
Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Regulating NF-B and Nrf2 Signaling Pathways.
Oxid Med Cell Longev. 2021 Jul 28;2021:1622375. doi: 10.1155/2021/1622375. eCollection 2021.
3
Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape.
Curr Gastroenterol Rep. 2021 Aug 2;23(9):16. doi: 10.1007/s11894-021-00816-3.
5
Compound Sophorae Decoction: treating ulcerative colitis by affecting multiple metabolic pathways.
Chin J Nat Med. 2021 Apr;19(4):267-283. doi: 10.1016/S1875-5364(21)60029-8.
6
Bu-Zhong-Yi-Qi Granule Enhances Colonic Tight Junction Integrity via TLR4/NF-B/MLCK Signaling Pathway in Ulcerative Colitis Rats.
Evid Based Complement Alternat Med. 2021 Mar 9;2021:6657141. doi: 10.1155/2021/6657141. eCollection 2021.
10
Curcumin Regulated the Homeostasis of Memory T Cell and Ameliorated Dextran Sulfate Sodium-Induced Experimental Colitis.
Front Pharmacol. 2021 Feb 1;11:630244. doi: 10.3389/fphar.2020.630244. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验